簡要描述:FXYD離子轉(zhuǎn)運調(diào)節(jié)因子7抗體免 疫 原;KLH conjugated synthetic peptide derived from human FXYD7: 21-60/80
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細介紹
FXYD離子轉(zhuǎn)運調(diào)節(jié)因子7抗體
產(chǎn)品名稱 | 英文名稱 | 貨號 |
FXYD離子轉(zhuǎn)運調(diào)節(jié)因子7抗體 | FXYD7 | GOY-01K4493 |
商品屬性:
英文名稱: FXYD7
中文名:FXYD離子轉(zhuǎn)運調(diào)節(jié)因子7抗體
別 名;FLJ25096; FXYD
domain containing ion transport regulator 7; FXYD domain-containing ion
transport regulator 7; Fxyd7; FXYD7_HUMAN.
研究領(lǐng)域;腫瘤 細胞生物 信號轉(zhuǎn)導 轉(zhuǎn)運蛋白
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應;(predicted:
Human, Mouse, Rat, Cow, Sheep, )
產(chǎn)品應用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復)
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;9kDa
細胞定位;細胞膜
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH conjugated
synthetic peptide derived from human FXYD7: 21-60/80
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件;Shipped at
4℃. Store at -20 °C for one
year. Avoid repeated freeze/thaw cycles.
注意事項;This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
This reference sequence was derived from multiple
replicate ESTs and validated by similar human genomic sequence. This gene
encodes a member of a family of small membrane proteins that share a 35-amino
acid signature sequence domain, beginning with the sequence PFXYD and
containing 7 invariant and 6 highly conserved amino acids. The approved human
gene nomenclature for the family is FXYD-domain containing ion transport
regulator. Transmembrane topology has been established for two family members
(FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on
the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit
of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1
(phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC)
have been shown to induce channel activity in experimental expression systems.
This gene product, FXYD7, is novel and has not been characterized as a
protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D.,
[email protected]., Dec 2000]. Subcellular Location: Membrane; Single-pass membrane protein
(Potential). |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價達到1:32000,由蛋白抗原制備的多抗,保證WB檢測結(jié)果是陽性。技術(shù)服務(wù)實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項目實際需求情況靈活選擇進行,我公司將為您的項目提供專業(yè)的建議。在制備過程中,與客戶互動驗證,確保最終制備的抗體ELISA陽性血清檢測達到合同要求的同時,也能滿足客戶抗體最終應用驗證需求。技術(shù)服務(wù)實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
重組抗體表達服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達等先進平臺,能為客戶提供各種類型的重組抗體表達服務(wù),包含鼠源單克隆抗體構(gòu)建及表達、更換恒定區(qū)亞型的嵌合抗體表達,抗體人源化改造及表達等服務(wù)。
單項免疫學及檢測服務(wù):
我公司也為客戶提供單項免疫學和檢測服務(wù),如動物免疫、動物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標記)、以及ELISA,WB,IHC,DB等檢測服務(wù)。
抗體定制服務(wù):
已注冊商標,主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對有特定應用要求和各種模型測試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃